atorvastatin has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Q; He, XY; Xiao, YH; Yang, F; Zhou, SX | 1 |
1 other study(ies) available for atorvastatin and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Atorvastatin prevents glomerular extracellular matrix formation by interfering with the PKC signaling pathway.
Topics: Atorvastatin; Cell Line, Transformed; Extracellular Matrix; Glomerular Mesangium; Humans; Platelet Activating Factor; Protein Kinase C beta; Signal Transduction; Transforming Growth Factor beta1 | 2018 |